Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2014-10-03 Director's Dealing
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2014-10-03 English
PRIMARY DOCUMENT
Director's Dealing
2014-10-03 English
PRIMARY DOCUMENT
Director's Dealing
2014-10-03 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated October 2, 2014, by Mesa Laboratories, Inc. The content focuses on the submission of matters to a vote of security holders at the Annual Meeting of Shareholders, including election results of directors, approval of executive compensation, approval of an equity plan, and ratification of the appointment of the independent registered public accounting firm. The document provides detailed voting results for these matters. This matches the description of a Declaration of Voting Results & Voting Rights Announcements (DVA) filing, which reports official results from shareholder votes at any general meeting. The document length is 3645 characters, which is consistent with a voting results announcement rather than a full annual report or other detailed report. Therefore, the correct classification is DVA with high confidence.
2014-10-02 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details amendments to the company's bylaws, including changes to shareholder meeting requirements, notice procedures for board meetings, and banking relationship approvals. It also references the filing of amended and restated bylaws as an exhibit. There are no financial statements or comprehensive financial data presented, nor is this an annual or quarterly report. The document is not a proxy statement, earnings release, or any other report type but rather a regulatory filing announcing corporate governance changes. Given the nature of Form 8-K and the content focusing on amendments to bylaws, this fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit more specific categories.
2014-10-02 English
PRIMARY DOCUMENT
Director's Dealing
2014-09-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.